Multisite study validates nanopore long-read sequencing for complex carrier-screening loci
A five-laboratory evaluation published as a preprint on bioRxiv finds that an amplification-based Oxford Nanopore workflow can reliably detect clinically relevant variants in genes with architectures that challenge short-read methods.
Researchers across five laboratories have evaluated a modular, amplification-based long-read sequencing workflow using Oxford Nanopore Technology for carrier screening at genomic loci that are notoriously difficult for standard short-read sequencing. The preprint, posted to bioRxiv on 19 May 2026, targeted genes associated with spinal muscular atrophy (SMA), thalassaemia, and cystic fibrosis — conditions where complex genomic architecture, pseudogenes, or repeat elements can cause short-read platforms to miss pathogenic variants.
The multisite design is a methodological strength: by running the same workflow across five independent laboratories and applying automated variant analysis, the study provides an early assessment of inter-laboratory reproducibility. Targeted PCR enrichment was used to prepare libraries prior to Nanopore sequencing, and the authors report that the approach successfully interrogated the relevant loci in a unified assay rather than requiring condition-specific workflows.
The work has not yet undergone peer review. As a preprint, the findings should be interpreted cautiously pending independent assessment. If the results are replicated and the method is validated in peer-reviewed studies, this class of long-read carrier-screening workflow could inform how laboratories approach technically challenging regions of the genome in research and clinical genetics contexts. Researchers in sequencing methodology, genetic counsellors tracking laboratory technology developments, and educators covering genomics methods will find the study relevant.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Some inherited conditions — such as spinal muscular atrophy and certain types of anaemia — are caused by changes in parts of the DNA that are difficult to read accurately with standard genetic testing methods. Researchers at five laboratories have tested a newer approach called long-read sequencing, which can read longer stretches of DNA at once, making it better suited to these tricky regions.
The study, which has been shared online but has not yet been checked by independent scientists (a stage called peer review), found that the method worked consistently across all five laboratories using a single, unified test.
If confirmed by further research, this type of approach might help laboratories detect a wider range of inherited variants in future. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary sourcePreprint bioRxiv (Cold Spring Harbor Laboratory) · 2026-05-19Multisite Evaluation of an Amplification-based Nanopore Sequencing Solution to Analyze Challenging Clinically Relevant Variants in Genes Associated with Hereditary Diseases